Ser Educacional (SEER3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 May, 2026Executive summary
Achieved 112.1% year-over-year growth in adjusted net income, reaching R$76.9 million in 4Q25, and a 29.8% reduction in net debt, with leverage at its lowest since Q1 2021.
Adjusted EBITDA margin expanded by 2.9 percentage points to 26.3%, with adjusted EBITDA up 22.8% to R$150.4 million.
Hybrid education and medical school expansion drove robust cash generation, operational optimization, and consistent profitability.
Six new units became operational, with further expansion planned, focusing on healthcare and law programs in non-capital cities.
Dividend payments of R$61 million were resumed, with a semi-annual policy targeting 30% of net earnings.
Financial highlights
Consolidated net revenue grew 9.4% year-over-year to R$572.9 million in 4Q25, with hybrid learning revenue up 12.3% and digital learning revenue down 7.0%.
Adjusted EBITDA rose 22.8% to R$150.4 million, with margin expanding to 26.3%.
Net income reversed from a loss of R$30 million to a profit of R$74.6 million in 4Q25, with recurring profit nearly doubling.
Net operating cash generation post-CapEx increased 227.9% to R$74.5 million, driven by improved payment punctuality and receivables anticipation.
CapEx decreased to R$23.0 million, representing 4.0% of net revenues.
Outlook and guidance
Strategic focus for 2026 includes organic growth, new unit openings, medical course expansion, and operational efficiency, especially in healthcare and law.
CapEx expected to return to 5%-6% of net revenue, supporting expansion and new unit openings.
Dividend policy reinstated, with semi-annual payments of 30% of net earnings.
Leverage target set between 0.6 and 0.8, balancing growth and shareholder returns.
Latest events from Ser Educacional
- Net income rose 74% with strong on-campus growth, higher margins, and lower net debt.SEER3
Q1 202614 May 2026 - Adjusted net income rose 8.5% to R$46.2M, with strong hybrid and health course growth.SEER3
Q2 20242 Feb 2026 - Revenue and EBITDA surged as leverage fell, led by health and medicine course expansion.SEER3
Q3 202414 Jan 2026 - Strong earnings, cash generation, and medical course expansion drive margin and debt improvement.SEER3
Q4 202427 Dec 2025 - Record profitability in 1Q25 fueled by hybrid and medical education growth and margin gains.SEER3
Q1 202526 Nov 2025 - Net income up 66.4%, hybrid enrollment up 13.8%, and net debt/EBITDA down to 1.24x.SEER3
Q2 202523 Nov 2025 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025 - Hybrid learning growth and operational gains drove profitability and lower net debt in Q1 2024.SEER3
Q1 20243 Jun 2025